CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-27 | GRAMMER ELIZABETH A | Sale | −1,446 | $7.54 | $11K | 117,986 |
| 2020-04-27 | GRAMMER ELIZABETH A | Sale | −2,500 | $7.52 | $19K | 115,486 |
| 2020-04-27 | GRAMMER ELIZABETH A | Sale | −3,542 | $7.49 | $27K | 111,944 |
| 2020-04-27 | GRAMMER ELIZABETH A | Sale | −10,336 | $7.44 | $77K | 101,608 |
| 2020-04-17 | RAAB MICHAEL President & CEO | Sale | −9,428 | $7.02 | $66K | 89,812 |
| 2020-04-16 | RAAB MICHAEL President & CEO | Sale | −10,500 | $7.01 | $74K | 99,240 |
| 2020-04-15 | RAAB MICHAEL President & CEO | Sale | −500 | $7.03 | $4K | 109,740 |
| 2020-03-12 | Cadoret-Manier Onaiza Director | Grant or award · Stock Option (Right to Buy) | +65,890 | 65,890 | ||
| 2020-03-02 | RAAB MICHAEL President & CEO | Exercise or conversion | +11,123 | $1.08 | $12K | 219,180 |
| 2020-03-02 | RAAB MICHAEL President & CEO | Sale | −11,123 | $7.00 | $78K | 208,057 |
| 2020-03-02 | RAAB MICHAEL President & CEO | Sale | −20,428 | $7.01 | $143K | 110,240 |
| 2020-03-02 | RAAB MICHAEL President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −11,123 | 0 | ||
| 2020-02-05 | RAAB MICHAEL President & CEO | Exercise or conversion | +25,000 | $1.08 | $27K | 231,828 |
| 2020-02-05 | RAAB MICHAEL President & CEO | Sale | −25,000 | $7.32 | $183K | 206,828 |
| 2020-02-05 | RAAB MICHAEL President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 11,123 | ||
| 2020-01-21 | Rosenbaum David P. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +47,500 | 47,500 |
Page 38 of 38 · 756 trades